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ORIGINAL ARTICLE
Lattice Microarchitecture for Bone Tissue Engineering
from Calcium Phosphate Compared to Titanium
Tse-Hsiang Chen, MS,1 Chafik Ghayor, PhD,1 Barbara Siegenthaler, PhD,1 Felix Schuler, MS,2
Jasmine Ru¨egg, MS,2 Michael De Wild, PhD,2 and Franz E. Weber, PhD1,3,4
Additive manufacturing of bone tissue engineering scaffolds will become a key element for personalized bone
tissue engineering in the near future. Several additive manufacturing processes are based on extrusion where the
deposition of the filament will result in a three-dimensional lattice structure. Recently, we studied diverse lattice
structures for bone tissue engineering realized by laser sintering of titanium. In this work, we used lithography-
based ceramic manufacturing of lattice structures to produce scaffolds from tricalcium phosphates (TCP) and
compared them in vivo to congruent titanium scaffolds manufactured with the identical computer-aided design
data to look for material-based differences in bony healing. The results show that, during a 4-week period in a
noncritical-size defect in a rabbit calvarium, both scaffolds with the identical microarchitecture performed
equally well in terms of bony regeneration and bony bridging of the defect. A significant increase in both
parameters could only be achieved when the TCP-based scaffolds were doped with bone morphogenetic
protein-2. In a critical-size defect in the calvarial bone of rabbits, however, the titanium scaffold performed
significantly better than the TCP-based scaffold, most likely due to its higher mechanical stability. We conclude
that titanium and TCP-based scaffolds of the same microarchitecture perform equally well in terms of bone
regeneration, provided the microarchitecture meets the mechanical demand at the site of implantation.
Keywords: lithography, calcium phosphate, titanium, bone regeneration, bone repair, lattice architecture,
additive manufacturing, osteoconduction
Impact Statement
The microarchitecture of bone substitutes is an important factor for successful bone regeneration via osteoconduction; as is
the choice of the material. To dissect osteoconduction determined by bony bridging and bony regeneration of a defect in
material and microarchitectural elements, we produced scaffolds with congruent microarchitecture from titanium and TCP
by additive manufacturing. For the first time we could show that for open porous lattice microarchitectures, titanium and
TCP based scaffolds are equally osteoconductive, if they meet the mechanical demands of the defect.
Introduction
Autologous bone is still the gold standard bone sub-stitute and after blood the most frequent transplanted
material in clinics worldwide.1 Sincemany years, bone tissue
engineering is focused on substitution of autografts. However,
due to its limited supply, additional pain at the secondoperating
site, and donor site morbidity, smarter grafting methods are
needed that would overcome these issues.2 In recent years,
special emphasis has beengiven to theuseofmesenchymal stem
cells3–6 and bone morphogenetic proteins (BMPs7–9) to further
improve the performance of synthetic bone substitute materials.
The first one, however, is costly and time-consuming and the
second one has caused well-documented side effects reported
over the last decade.10 Therefore, the search for a bone substi-
tute, which can compete with autologous bone, is still ongoing.
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From the material point of view, bone is a composite from
collagen and calcium phosphate (CaP) deposited as hy-
droxyapatite. Therefore, CaP-based ceramics are the most
widely applied synthetic biomaterials for repair and regen-
eration of damaged and diseased bone.11 CaP not only re-
sembles natural bone mineral but is also bioactive in terms of
biocompatibility, osteoconductivity, and osteoinductivity.12
Its biocompatibility is evident by the direct bone bonding
capacity, its osteoconduction by the advancement of bone
deposition on the surface, and its osteoinduction by a limited
capacity to induce de novo bone formation close to CaP im-
plants. All these bioactivities of CaP are attributed to the
chemical composition, surface topography, macroporosity/mi-
croporosity, and the dissolution kinetics of the calcium (Ca2+)
and phosphate (PO4
3-) ions, as reviewed in Ref.12
To mimic cancellous autologous bone and allow bone in-
growth, CaP-based scaffolds are produced with a certain
porosity as reviewed in Ref.13 The ideal pore size was found
to be between 0.3 and 0.5mm. A more recent article reported
that no difference in bone regeneration was seen up to a pore-
size of 1.2mm.14 In all these porous CaP-based scaffolds used
for the identification of the ideal pore dimension, the pores
were introduced by porogens causing a random distribution of
the pores and no direct control over the size of the inter-
connections between the pores. To overcome these limitations
of all those studies, the application of additive manufacturing
produces scaffolds with defined pore sizes, pore locations,
microarchitecture, and defined connections between pores.
The process of additive manufacturing creates the scaffold
layer upon layer for example by stereolithography or selec-
tive laser sintering.15 In three-dimensional printing, another
methodology in additive manufacturing, the object is formed
in a powder bed by the deposition of a liquid binder through
inkjet heads.16 This methodology has already been applied for
ceramics,17 but certain limitations of design freedom exist to
allow the release of powder entrapped inside the scaffold
during the production in the powder bed.18 In recent years, we
aimed to study the ideal microarchitecture of bone substitutes
by selective laser sintering where a high-intensity laser beam
was used to build scaffolds in a titanium powder bed.19,20 We
found open titanium lattice structures to allow a fast defect
bridging, which could not be accelerated by the double de-
livery of BMPs and their enhancer.21 The disadvantage of
using a titanium-based bone substitute is its nondegradability.
Therefore, we looked for an additive manufacturing system to
produce filigree structures from ceramics.
In this study, we applied the CeraFab 7500 (Lithoz,
Vienna, Austria) for the production of lattice structures from
tricalcium phosphates (TCP), where fine structures are pro-
duced from a TCP slurry by a lithography-based printing
process in an upside-down process. In this study, we report on
the accuracy of the system and the morphology of the sin-
tered material. Moreover, we studied its performance in vivo
in comparison to titanium scaffolds produced by selective
laser melting out of the same digital information file data
(STL: standard triangulation language) in a noncritical cal-
varial defect and a critical calvarial defect model in rabbits.
By doing so, we were able to compare both widely accepted
materials in bone tissue engineering: titanium and TCP, for
osteoconduction quantified by bony bridging and bony re-
generation of the defects with scaffolds of identical micro-
architecture.
The aims of this study were to characterize a lithography-
based additively manufactured TCP scaffold and compare it
to a titanium-based scaffold with identical microarchitecture
in the context of bone tissue engineering. Moreover, we
wanted to compare the osteoconductivity of a lattice mi-
croarchitecture realized with two widely accepted, but very
distinct materials to test for material-dependent effects on
osteoconduction.
Methods
Implant production
Titanium implants were produced as previously reported.19,20
For critical-size defects, lattice implants with ø15mm outer
diameter were produced; for noncritical-size defects, ø6mm
scaffolds were produced. The microarchitecture of all implants
consists of orthogonal struts of ca. 300mm diameter separated
by ca. 500mmwide interconnected channels. The TCP scaffolds
were produced with a TCP slurry LithaBone TCP 200 (Li-
thoz, Vienna, Austria), solidified in the CeraFab 7500 system
(Lithoz) by the exposure of the photoactive polymer from the
slurry to a blue LED light in a layer-by-layer manner.22 The
so-formed TCP green part was composed of layers of 25 mm
thickness and a resolution of 50mm in the x/y-plane. Upon
cleaning of the green part with LithaSol 20 (Lithoz) and
pressurized air, they underwent a thermal treatment to de-
compose the polymeric binder and densify them by sintering.
The final stage of the sintering procedure covered a dwelling
time of 3 h at 1100C, as recommended by the manufacturer
of the slurry. The sintered scaffolds were transferred into a
sterile bench, packed for transportation into the operation
theater, and used as bone substitute implant without further
sterilization.
Scanning electron microscopy
The scaffolds were examined using a Zeiss Supra V50
scanning electron microscope (SEM) (Carl Zeiss, Oberko-
chen, Germany). Scanning was performed under accelera-
tion voltage of 12 kV with a distance of the sample to the
detector of 9.5 cm.
Surgical procedure
Twenty-four adult (12 months old) New Zealand White
rabbits were used in this study. The animals’ weights were
between 3.5 and 4.0 kg and they were fed a standard labo-
ratory diet. The procedures was evaluated and accepted by
the local authorities (108/2012 and 114/2015). To initiate
the operation, the animals were anesthetized by an injection
of 65mg/kg ketamine and 4mg/kg xylazine and maintained
under anesthesia with isoflurane/O2. After disinfection, an
incision from the nasal bone to the mid-sagittal crest was
made, the soft tissue deflected, and the periosteum removed.
Next, for noncritical-size defects, four evenly distributed
6-mm-diameter craniotomy defects were prepared with a
trephine bur under copious irrigation with sterile saline in
the operation field. Then, all defects were completed with
a rose burr (1mm) to preserve the dura. Next, all the de-
fects were flushed with saline solution to remove remain-
ing debris and the implants applied by gentle press fitting.
Each of the animals received four different treatment modali-
ties. The treatment modalities were assigned at random for the
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first animal, and thereafter, cyclic permuted clockwise. The
treatments were grouped for titanium, TCP, and TCP/BMP.
For the critical-size defects, a central 15-mm-diameter defect
was generated as reported recently.21 After the completion of
implant placement, the soft tissues were closed with inter-
rupted sutures. Fourweeks after operation for the 6mmdefects
and 16 weeks for the critical-size defects, the rabbits were
placed under general anesthesia and sacrificed by an overdose
of pentobarbital. The cranium containing all four craniotomy
sites was removed and placed in 40% ethanol. Embedding was
performed as previously reported.20
Histomorphometry
The evaluation of all implants was performed from the
middle section using image analysis software (Image-Pro
Plus; Media Cybernetic, Silver Springs, MD). The area of
interest (AOI) was defined by the 6mm, respectively,
15mm defect dimension and the height of the implant. We
determined the area of new bone in the AOI as percent of
bone and bony integrated scaffold in the AOI (bony area, %).
For the empty control value, the average area occupied by
all scaffolds was taken into account, since the height of the
implants exceeds the thickness of the calvarial bone.
Bone bridging
The determination of bony bridging was performed as
reported earlier.23,24 In brief, areas with bone tissue within
the defect margin were projected onto the x-axis. Next, the
stretches of the x-axis with projected bone tissue were
summed up and related to the defect width of 6mm (non-
critical size), respectively 15mm (critical size). Bone
bridging is given in percentage of the defect width (6mm,
respectively 15mm) where bone formation had occurred.
Statistics
The primary analysis unit was the animal. For all pa-
rameters tested, the treatment modalities were compared
with a Kruskal–Wallis test, followed by pairwise com-
parison of treatment modalities with the Mann–Whitney
test for dependent data (IBM SPSS v.19). p-Values are
displayed in the graphs and significance was set at a limit
of p < 0.05. Data from seven to nine different rabbits are
presented for each group for the noncritical-size defect and
six for the critical-size ones. Values are reported in the text
by mean – standard deviation or displayed in graphs as
median – lower/upper quartile.
FIG. 1. Characterization of a TCP scaffold for noncritical-size defects. (a, b) Top and side view of a TCP scaffold (lower
part is 6mm in diameter). Building direction is indicated by the red arrow. (c) Intraoperative view of TCP and titanium
scaffolds after placement into the cranial defects. The empty defect (lower left) serves as control. (d) Electron microscopical
view of the outer part of the scaffold. A pore and its height and width are indicated in orange. (e) Comparison of pore and
rod height and width from outside, inside, and in silico (STL file). (f) Electron microscopical top view of the inner (broken)
part of the scaffold. A rod and rod height and width are indicated in orange. The red arrow illustrates the building direction.
Scales are provided. TCP, tricalcium phosphates. Color images available online at www.liebertpub.com/tea
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Results
Characterization of the TCP-based scaffolds
and comparison to the virtual planning
After sintering, the scaffolds appeared white, suggesting
that all the binder material was removed during the sintering
process, including a 3-h sintering step at 1100C (Fig. 1a, b).
Next, we compared the produced scaffolds with the digital
information file data put down in an STL file. In terms of
precision, we evaluated the height and width of the pores and
rods from the outer surface of the scaffold in top view and from
the cross-section of the inner part as illustrated (Fig. 1d, f). The
comparison of the aforementioned dimensions taken from
the outside and the inner portion of the scaffold in com-
parison with the STL dimensions revealed that there are
deviations in the building direction (see arrow in Fig. 1a, f),
listed as pore height and rod height (Fig. 1e). These devia-
tions arose since in these initial studies, no compensation
parameters were used during the printing process; hence, a
higher cure depth in z-direction was obtained than targeted
in the CAD. SEM (Fig. 2) revealed that upon sintering, the
TCP particles have partially fused and the scaffold appears
to be highly microporous with pores between 2 and 4 mm in
diameter.
In vivo evaluation and comparison of TCP to titanium
One aim of this study was to compare the effect of the
bone substitute material (TCP or titanium) on bony bridging
and bony regenerated area in case the bone substitute had
the identical lattice microarchitecture. In a first series of
experiments, we compared bony bridging and bone forma-
tion between empty defects, titanium, TCP, and TCP scaf-
folds loaded with 10 mg BMP-2 in noncritical-size defects.
Since our model consists of four defects, the titanium im-
plant with BMP-2 was omitted and the new TCP implant
with BMP-2 was tested. The architecture of all scaffolds was
identical because they were built with the same STL file.
The histologies of the middle section (Fig. 3) revealed that
bone formation had occurred during the 4-week period
throughout all implants, irrespective of the material.
For quantification, the extent of bony bridging and bone
formation in the defect was determined (Fig. 4). In empty
defects, 29.28%– 19.16% of the middle section was bridged,
71.29%– 23.95% for titanium, 89.28%– 18.45% for TCP,
and 96.87% – 6.20% for TCP plus BMP-2, respectively. In
the AOI, the percentage of bony regeneration in the middle
section was 16.40% – 6.79% for empty defects, 39.00% –
9.14% for titanium, 56.94%– 19.08% for TCP, and 73.13%–
13.94% for TCP plus BMP-2, respectively. For both mea-
sures, all scaffolds performed better than the empty defects.
No significant difference existed between titanium and TCP
scaffolds. Only if doped with 10 mg BMP-2, the TCP-BMP
scaffold performed significantly better than the titanium
scaffold, both in terms of bony bridging ( p= 0.008) and
bony regenerated area ( p = 0.001). This result also suggests
that our additively manufactured TCP scaffolds could serve
as BMP-2 delivery vehicle and combine osteoconduction
with osteoinduction.
Critical-size defect
To compare identical lattice-based microarchitectures from
titanium and TCP in more detail we, next, moved to a critical-
size defect in the calvarial bone of rabbits. The scaffolds for
this aspect were produced as mentioned before (Fig. 5a), with
the diameter of the lower part of 15mm adjusted to critical-
size defects21 (Fig. 5b). The samples were harvested 16
weeks after implantation. Histology revealed that the majority
of the defect was bridged, although the scaffolds appeared
partially disintegrated (Fig. 5c). The reason for this behavior
is most likely related to the high microporosity of the TCP
samples. This microporosity on the one hand enables rapid
resorption of the materials, but on the other hand also in-
creases the brittleness of the resulting scaffolds. This brittle
behavior in combination with very delicate struts and with
FIG. 2. SEM of a broken TCP rod. (a–d)
Shows the final scaffold after sintering,
Scales are provided in the panels. TCP par-
ticles and micropores appear 2–4mm in di-
ameter. SEM, scanning electron microscopy.
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stresses arising from press-fit application of the implants can
lead to partial disintegration of the TCP scaffold already
during the placement of the implant.
Another important factor for this behavior is that mate-
rials such as TCP inherently have different material
properties compared to metals. For future studies, this
needs to be accounted for by choosing a scaffold design
compliant with the mechanical properties of TCP, in par-
ticular if applied in critical-size defects. In empty critical
15mm defects, 40.13% – 16.39% of the middle section was
bony bridged after 16 weeks in vivo, 92.13%– 11.45% for
titanium, and 66.93%– 14.19% for TCP, respectively. In the
AOI, the percentage of bony regeneration in themiddle section
was 23.72%– 10.02% for empty defects, 42.67%– 7.38% for
titanium, and 31.51%– 7.54% for TCP, respectively. Com-
pared to the untreated defect, bony regenerated area was sig-
nificantly improved for titanium implants only (Fig. 5d). Bony
bridging, however, was significantly improved for both bio-
materials, titanium and TCP (Fig. 5e). In direct comparison,
the percentage of bony bridging of the defect was significantly
higher in titanium scaffolds than in TCP scaffolds. This is seen
as clear indication that in the case of a critical-size defect, the
mechanical strength of the scaffolds has to be ensured. Since
the applied microarchitecture of the titanium scaffold was
sufficient to heal the critical-size defect, an additional stimu-
lation by BMP-2 was not tested in this model system.
Discussion
Cranial defect models are widely used for the testing of
bone substitute materials.25–27 Less known is the fact that
cranial defects are clinically highly relevant in congenital
anomalies, trauma, stroke, aneurysms, and cancer.28 For
preclinical testing, the low mechanical challenge posed in
the cranium is an advantage, since it allows the testing of
diverse materials without the need for costly fracture fix-
ation devices, needed in long bone defect treatments.
Additive manufacturing facilitates the realization of 3D
objects in microarchitectural designs coded in computer fi-
les, predominantly in STL format (STereoLithography or
Surface TrianguLated). In this study, we manufactured bone
substitute scaffolds from TCP by a lithography-based
methodology, characterized them, and compared their per-
formance in vivo with titanium-based scaffolds produced
with the identical STL file by selective laser melting. The
results showed that in a noncritical defect, both scaffolds
with identical microarchitecture, but from distinct bioma-
terials and surfaces performed equally well. In a critical-size
FIG. 3. Histological sections from the
middle of the noncritical-size defect. (a–d)
For all scaffolds and the untreated control, a
histological section from 4 weeks postoper-
atively is shown. (a) Empty control defect;
(b) titanium scaffold; (c) TCP scaffold with
10 mg BMP-2; (d) TCP scaffold. Scale bars
indicate 1mm. Original magnifications were
100 fold. Bone appears as grayish purple to
purple, titanium as dark black, and TCP as
grayish black. BMP, bone morphogenetic
protein. Color images available online at
www.liebertpub.com/tea
FIG. 4. Histomorphometric parameters for bone regeneration in noncritical-size defects 4 weeks postoperatively. The
formation of new bone (a) and defect bridging (b) is significantly elevated in defects treated with scaffolds compared to empty
defects. Titanium and TCP scaffolds with identical architecture performed equally well in both categories. A significant
increase could only be detected between the titanium and the TCP scaffolds when the latter was doped with 10mg BMP-2.
Values are displayed as box plots ranging from the 25th (lower quartile) to the 75th (upper quartile) percentile, including the
median as solid black line and whiskers, showing the minimum and maximum values. Values outside the range of the box blot
are shown as individual points. p Values are provided in the graphs. Color images available online at www.liebertpub.com/tea
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defect, where the mechanical demand is higher, the
titanium-based scaffold was superior, most likely due to the
higher mechanical strength of titanium compared to TCP.
Thus, for critical-size defects, the brittleness of TCP-based
scaffolds will have to be compensated by using different
design guidelines for TCP scaffolds as suitable for titanium.
Creeping substitution of the implant over time by bone
tissue is the ideal endpoint of a bone regeneration procedure.
Therefore, we looked into additive manufacturing of TCP,
since it remains biodegradable even after undergoing high
temperature sintering.29,30 For the production of personal-
ized bone substitutes, the produced implant has to match the
digital information deduced from computer tomographies.
The lithography-based production of TCP scaffolds by the
CeraFab 7500 system matches the lateral dimension of
the planned STL file information. However, the height of
the pores and rods along the building direction appear
compressed (Fig. 1e). The deviation in z-direction derives
from a curing depth that is higher than the thickness of an
individual layer. This increased cure depth is necessary to
ensure good adhesion between adjacent layers. The viscosity
of the slurry could also play a minor role in this aspect.
Deviation in the z-axis can be corrected before production
by software compensation algorithms to adjust the detailed
geometry of the STL file. Moreover, for scaffolds meant
for bone tissue engineering, a high precision of the micro-
architecture might not be the decisive factor, as long as the
structure is widely open, porous, accessible for proteins,
blood, and cells, and optimized for bone ingrowth by os-
teoconduction. This has been shown when a library of di-
verse open porous titanium scaffolds was tested in vivo in
the same model system.20 The outer dimension, however,
should perfectly match the defect, to produce personalized
bone substitutes, which is the main advantage of the appli-
cation of additive manufacturing for bone substitute pro-
duction, especially if complex shapes have to be realized.31
Titanium and TCP, both are known for their suitability to
serve as bone substitute biomaterial.32 In this study, we
show that if scaffolds from titanium and TCP are produced
with the identical microarchitecture as wide open porous
lattice structures, both materials support osteoconduction,20
defined in this study as bone ingrowth into porous structures
(Fig. 4a) and as guiding cue to achieve defect bridging
(Fig. 4b). Therefore, with the lithography-based additive
manufacturing procedure, as used in this study, personal-
ized osteoconductive scaffolds can be produced from TCP
and other permanent or biodegradable ceramics like hy-
droxyapatite or bioglass. Since these ceramics vary in their
mechanical characteristics, the bone substitute scaffolds
can be adjusted to the mechanical need at the operation site
with the right choice of the ceramic without changing the
microarchitecture or macroarchitecture.
Recent studies have reported on bone ingrowth and the
presence of cells also in micropores, well below 0.1mm in
diameter.33,34 The positive effect of microporosity on bone
formation was suggested to reflect a better attachment of
proteins to the surface, increased degradation products, and
capillary forces (as reviewed in Ref.35). In our study, we
FIG. 5. Critical-size defect. (a) TCP-based implant for critical-size rabbit calvarial bone defect. (b) Intraoperative view on
an implanted scaffold. (c) Histological section of the middle of the defect 16 weeks postoperatively. The TCP appears
grayish black and bone purple. The distorted lattice structure and gaps between rods indicate a failure of the scaffold. The
formation of new bone (d) and defect bridging (e) is significantly elevated in defects treated with titanium scaffolds
compared to empty defects. For TCP scaffolds with identical architecture, only defect bridging was significantly improved
compared to empty, untreated defects. While no significant difference was evident for bony area between both materials, for
bony bridging, titanium performed significantly better than TCP. Values in (d, e) are displayed as box plots ranging from the
25th (lower quartile) to the 75th (upper quartile) percentile, including the median as solid black line and whiskers, showing
the minimum and maximum values. Values outside the range of the box blot are shown as individual points. p Values are
provided in the graphs. Color images available online at www.liebertpub.com/tea
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compared a microporous TCP-based scaffold (Fig. 2) to a
material without pores (titanium) and could not detect a
significant difference in defect bridging or regenerated
bony area for wide open porous lattice structures. This is in
line with other in vivo studies in sheep, where different
levels of microporosity in TCP-based scaffolds had no
effect on bony healing.36
To our knowledge, this is the first direct comparison of
a metal and a ceramic with the identical microarchitecture
in vivo, pointing to the importance of the microarchitecture
for osteoconduction and bone regeneration. When using
scaffold designs of the exact same geometry, significant
differences in terms of the mechanical integrity became
visible for the critical-size defects (Fig. 5). These short-
comings of the brittle TCP scaffolds will have to be
compensated by tailoring and improving the scaffold de-
signs. It could be verified that a geometry working well for
dense and ductile materials such as titanium is not neces-
sarily the best fit for other types of materials, especially
outside the material class of metals. For small noncritical
defects, TCP-based scaffolds performed excellently. The
anticipated difference in degradation capability will have
long-time effects and was not subject of this study.
By selecting the right ceramic in combination with the right
scaffold microarchitecture, mechanical demands or degrada-
tion characteristics can be tuned to the need of individual
patients in cranio-maxillofacial surgery, orthopedics, trauma,
or dentistry. Especially in terms of developing optimized
scaffold designs, which are compliant with the property
profile of ceramics such as TCP, additional research is nec-
essary to improve the performance of such implants.
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